Medcorp Limited (TTSE:MED)
Trinidad and Tobago flag Trinidad and Tobago · Delayed Price · Currency is TTD
44.00
0.00 (0.00%)
At close: Apr 7, 2026

Medcorp Income Statement

Millions TTD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
121.7122.24127.02122.22114.19
Revenue Growth (YoY)
-0.44%-3.76%3.92%7.03%10.46%
Cost of Revenue
57.1859.685661.8156.05
Gross Profit
64.5262.5571.0260.4158.14
Selling, General & Admin
43.8938.6433.2432.0828.4
Other Operating Expenses
-1.680.55-1.66-3.19-5.25
Operating Expenses
42.2139.1931.5928.8923.15
Operating Income
22.3123.3639.4331.5234.99
Interest Expense
-4.34-5.95-3.21-2.45-2.31
Interest & Investment Income
--30.69--
Earnings From Equity Investments
2.454.834.981.721.99
EBT Excluding Unusual Items
20.4222.2471.8930.7934.66
Gain (Loss) on Sale of Assets
---00.12-
Other Unusual Items
-25.93---
Pretax Income
20.4248.1771.8930.9134.66
Income Tax Expense
2.246.8614.826.7810.17
Net Income
18.1841.3157.0724.1324.49
Net Income to Common
18.1841.3157.0724.1324.49
Net Income Growth
-55.99%-27.62%136.53%-1.49%38.74%
Shares Outstanding (Basic)
87777
Shares Outstanding (Diluted)
87777
Shares Change (YoY)
2.55%----
EPS (Basic)
2.375.527.633.233.27
EPS (Diluted)
2.375.527.633.233.27
EPS Growth
-57.08%-27.62%136.53%-1.49%-
Free Cash Flow
22.7620.1228.7125.415.66
Free Cash Flow Per Share
2.972.693.843.400.76
Dividend Per Share
-4.000--4.500
Gross Margin
53.01%51.17%55.92%49.43%50.91%
Operating Margin
18.33%19.11%31.05%25.79%30.64%
Profit Margin
14.94%33.79%44.93%19.74%21.45%
Free Cash Flow Margin
18.70%16.46%22.60%20.79%4.96%
EBITDA
38.5128.5544.6236.6736.91
EBITDA Margin
31.64%23.36%35.13%30.00%32.32%
D&A For EBITDA
16.25.195.185.141.92
EBIT
22.3123.3639.4331.5234.99
EBIT Margin
18.33%19.11%31.05%25.79%30.64%
Effective Tax Rate
10.96%14.25%20.62%21.94%29.34%
Advertising Expenses
-0.240.170.20.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.